Comparison of the efficacy of intralesional versus intramuscular injection Meglumine Antimoniate in the treatment of sores of Cutaneous Leishmaniasis

Posted on Author: .

About admin

Professor, Consultant Pathologist, American Board Certified Pathologist, Fellow College of American Pathologists. Areas of interest Fine Needle Aspiration Cytology, Cytology, Cancer, Ethics, Islam, Humanity

Comparison of the efficacy of intralesional versus intramuscular injection Meglumine Antimoniate in the treatment of sores of Cutaneous Leishmaniasis

*Attiya Tareen, ** Syed Afaq Ahmad, **Ikramullah Khan

* Department of Dermatology, Fauji Foundation Hospital, Rawalpindi, Pakistan, ** Department of Dermatology

Pakistan Institute of Medical Sciences Islamabad, Pakistan

Objectives: To compare the efficacy of intralesional with intramuscular injection meglumine antimoniate in the treatment of Cutaneous Leishmaniasis.

Design: Prospective, comparative, interventional study.

Setting: Pakistan Institute of Medical Sciences, [PIMS] Islamabad.

Material and Methods: Seventy six (40 males, 36 females) consecutive patients with sores of Cutaneous Leishmaniasis presenting to the Dermatology department, underwent treatment with Intralesional (1 ml/cm2 of Sb) or Intramuscular injection Meglumine antimoniate ((20 mg Sb/kg/day for 21 to 28 days) according to the selection criteria for each group from April 2004 to March 2005. On the basis of demonstration of Leishmania tropica (LT) bodies in the skin slit smears/skin biopsies, 76 patients were included in the study and were followed-up for therapeutic safety and efficacy at different intervals. After completing local or systemic treatment, cure rate was calculated by observing the improvement criteria i.e. flattening, softening, decrease in size of lesion and absence of erythema, induration, . According to the sample selection procedure for the two modalities of treatment 46 (60.5%) patients were found suitable for Intralesional therapy and 30(39.5%) were found suitable for Intramuscular therapy.

Results: Males 40(52.6%) constituted a slightly greater number than females 36(47%) The final outcome of intralesional injection meglumine antimoniate at weekly intervals in 46 patients was that 44 (95.65%) got completely cured, whereas among those receiving I/M therapy 25(83.3%) got cured with their lesions getting almost flattened and itch/pain subsided. Z test for proportion was used for comparison which was Z=1.75 showing that proportion of cured patients with IL treatment was greater than IM treatment (P= 0.027 =<0.05) which confirms that there is a significant relationship between route of administration and outcome of lesion .The average number of injections required for 1/L was found to be 6 at weekly intervals and 18 for 1/M treatment. Both the treatments were given according to the recommended guidelines of WHO.

Design: Prospective, comparative, interventional study.

Conclusion: Intralesional therapy is superior to Intramuscular therapy with meglumine antimoniate in terms of efficacy, safety, outcome.

Key Words: Cutaneous Leishmaniasis CL, Meglumine antimoniate, Intramuscular [I/M], Intralesional [I/L].

         

 Download PDF